STOK Net Income Growth
Period ending:
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
STOK net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 27 observations from Dec 31, 2019 to Jun 30, 2026.
| Period ending | Net Income Growth |
|---|---|
| -496.1245% | |
| -437.6969% | |
| 92.2624% | |
| 138.4678% | |
| 150.6754% | |
| 146.3217% | |
| 15.0126% | |
| -1.9933% | |
| 1.33% | |
| -9.6652% | |
| -3.5937% | |
| -3.541% | |
| -8.9459% | |
| -5.6608% | |
| -17.7868% | |
| -31.5367% | |
| -43.7893% | |
| -61.4928% | |
| -64.2421% | |
| -58.6848% | |
| -56.6929% | |
| -54.1571% | |
| -61.6179% | |
| -80.8976% | |
| -102.0888% | |
| -130.0899% | |
| -158.1663% |
Compare net income growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) net income growth
- Ensign Group Inc (ENSG) net income growth
- Krystal Biotech Inc (KRYS) net income growth
- Protagonist Therapeutics Inc (PTGX) net income growth
- Tg Therapeutics Inc (TGTX) net income growth
- Healthequity Inc (HQY) net income growth
- Pacs Group Inc (PACS) net income growth
- Alkermes (ALKS) net income growth
Compare all covered stocks by net income growth →
All STOK financial metrics · STOK stock overview · How to interpret financial metrics